Indian Angel Network has achieved a final close of $53m for its inaugural fund thanks to limited partners including Hyundai, Max Group, India Infoline and Yes Bank.

Astellas has re-invested in Coda Biotherapeutics, which is working on therapies for conditions such as focal epilepsy and chronic neuropathic pain.

Emerging Technology Partners has returned for a $30m round for HLI, which last closed a $220m series B three years ago backed by Illumina, Celgene and GE.

Health provision integration platform Healthify has now raised $28m in equity and grants after a series B round involving BlueCross BlueShield Venture Partners.

Honeywell Ventures was among the investors in drug manufacturing informatics company Bigfinite’s latest round, with the proceeds slated to grow the market for its platform.

MIT-founded machine learning software development engine company Neural Magic picked up support from Comcast Ventures for its approach to executing ML models on commodity CPUs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Lilly Asia Ventures returned for a $100m series C round, after the corporate venturing unit previously also backed a series B round of undisclosed size last year.

Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.